Cargando…

Established and Emerging Mechanisms of Diabetic Cardiomyopathy

Diabetes mellitus increases the risk for the development of heart failure even in the absence of coronary artery disease and hypertension, a cardiac entity termed diabetic cardiomyopathy (DC). Clinically, DC is increasingly recognized and typically characterized by concentric cardiac hypertrophy and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gollmer, Johannes, Zirlik, Andreas, Bugger, Heiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Lipidology and Atherosclerosis 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379081/ https://www.ncbi.nlm.nih.gov/pubmed/32821697 http://dx.doi.org/10.12997/jla.2019.8.1.26

Ejemplares similares

Mitochondrial Mechanisms in Diabetic Cardiomyopathy
por: Gollmer, Johannes, et al.
Publicado: (2020)

Complications and mortality of cardiovascular emergency admissions during COVID-19 associated restrictive measures
por: Bugger, Heiko, et al.
Publicado: (2020)

Impact of COVID-19 on Cardiovascular Disease
por: Vosko, Ivan, et al.
Publicado: (2023)

Diabetic Cardiomyopathy: Does the Type of Diabetes Matter?
por: Hölscher, Maximilian E., et al.
Publicado: (2016)

Mitochondrial Mechanisms in Septic Cardiomyopathy
por: Cimolai, María Cecilia, et al.
Publicado: (2015)

Myocardial Deformation Analysis in MYBPC3 and MYH7 Related Sarcomeric Hypertrophic Cardiomyopathy—The Graz Hypertrophic Cardiomyopathy Registry
por: Höller, Viktoria, et al.
Publicado: (2021)

Cellular Heterogeneity of the Heart
por: Anto Michel, Nathaly, et al.
Publicado: (2022)

Established and Emerging Mechanisms in the Pathogenesis of Arrhythmogenic Cardiomyopathy: A Multifaceted Disease
por: Gao, Shanshan, et al.
Publicado: (2020)

Dysregulation of the Mitochondrial Proteome Occurs in Mice Lacking Adiponectin Receptor 1
por: Pepin, Mark E., et al.
Publicado: (2019)

Mass Spectrometry-Based Redox and Protein Profiling of Failing Human Hearts
por: Tomin, Tamara, et al.
Publicado: (2021)

NAD(+) and Vascular Dysfunction: From Mechanisms to Therapeutic Opportunities
por: Abdellatif, Mahmoud, et al.
Publicado: (2022)

Emerging Therapy for Diabetic Cardiomyopathy: From Molecular Mechanism to Clinical Practice
por: Hsuan, Chin-Feng, et al.
Publicado: (2023)

Outcomes of ECLS-SHOCK Eligibility Criteria Applied to a Real-World Cohort
por: von Lewinski, Dirk, et al.
Publicado: (2023)

Effects of Short Term Adiponectin Receptor Agonism on Cardiac Function and Energetics in Diabetic db/db Mice
por: Tarkhnishvili, Aleksandre, et al.
Publicado: (2022)

Of mice and men: models and mechanisms of diabetic cardiomyopathy
por: Riehle, Christian, et al.
Publicado: (2018)

Editorial of Special Issue “Sirtuins in Health and Disease”
por: Sedej, Simon, et al.
Publicado: (2021)

Resveratrol and Diabetic Cardiomyopathy: Focusing on the Protective Signaling Mechanisms
por: Song, Yan-Jun, et al.
Publicado: (2020)

The Molecular Mechanisms of Defective Copper Metabolism in Diabetic Cardiomyopathy
por: Cui, Xiangning, et al.
Publicado: (2022)

Mitochondrial Quality Control Mechanisms during Diabetic Cardiomyopathy
por: Ketenci, Melis, et al.
Publicado: (2022)

Role of Echocardiography in Diabetic Cardiomyopathy: From Mechanisms to Clinical Practice
por: Urlic, Hrvoje, et al.
Publicado: (2023)

Established and emerging treatments for diabetes-associated lower urinary tract dysfunction
por: Erdogan, Betül R., et al.
Publicado: (2022)

SIRT3 in Cardiac Physiology and Disease
por: Koentges, Christoph, et al.
Publicado: (2016)

Diabetic cardiomyopathy
por: Asghar, Omar, et al.
Publicado: (2009)

Cellular mechanisms of cardiomyopathy
por: Harvey, Pamela A., et al.
Publicado: (2011)

Mechanical aberrations in hypetrophic cardiomyopathy: emerging concepts
por: Ntelios, Dimitrios, et al.
Publicado: (2015)

Functional remodelling of perinuclear mitochondria alters nucleoplasmic Ca(2+) signalling in heart failure
por: Voglhuber, Julia, et al.
Publicado: (2022)

Insights into SGLT2 inhibitor treatment of diabetic cardiomyopathy: focus on the mechanisms
por: Huang, Keming, et al.
Publicado: (2023)

Diabetic cardiomyopathy and its mechanisms: Role of oxidative stress and damage
por: Liu, Quan, et al.
Publicado: (2014)

Emerging Medical Treatment for Hypertrophic Cardiomyopathy
por: Argirò, Alessia, et al.
Publicado: (2021)

Mitophagy in Diabetic Cardiomyopathy: Roles and Mechanisms
por: Zheng, Haoxiao, et al.
Publicado: (2021)

The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms
por: Salvatore, Teresa, et al.
Publicado: (2021)

Exercise as A Potential Therapeutic Target for Diabetic Cardiomyopathy: Insight into the Underlying Mechanisms
por: Seo, Dae Yun, et al.
Publicado: (2019)

Molecular mechanism of diabetic cardiomyopathy and modulation of microRNA function by synthetic oligonucleotides
por: Ghosh, Nilanjan, et al.
Publicado: (2018)

Mitochondrial quality control in diabetic cardiomyopathy: from molecular mechanisms to therapeutic strategies
por: Cai, Chen, et al.
Publicado: (2022)

Roles and Mechanisms of Herbal Medicine for Diabetic Cardiomyopathy: Current Status and Perspective
por: Tian, Jinfan, et al.
Publicado: (2017)

Cellular and molecular mechanisms, genetic predisposition and treatment of diabetes-induced cardiomyopathy
por: Sharma, Urvashi, et al.
Publicado: (2022)

Diabetic cardiomyopathy: Early diagnostic biomarkers, pathogenetic mechanisms, and therapeutic interventions
por: Huo, Jin-Ling, et al.
Publicado: (2023)

Predictors and prevention of diabetic cardiomyopathy
por: Chavali, Vishalakshi, et al.
Publicado: (2013)

Diagnostic approaches for diabetic cardiomyopathy
por: Lorenzo-Almorós, A., et al.
Publicado: (2017)

Role of inflammation in diabetic cardiomyopathy
por: Ramesh, Pranav, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q7dura5tkk37k906m5100a8f9f